Page last updated: 2024-08-24

nelfinavir and Cancer of Rectum

nelfinavir has been researched along with Cancer of Rectum in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beets, GL; Buijsen, J; Den Boer, MO; Jansen, RL; Lambin, P; Lammering, G; Leijtens, J; Riedl, RG; Sosef, M; Theys, J; Wals, J1
Anderson, EM; Blesing, C; Boyle, L; Brown, G; Chu, KY; Dutton, S; Enescu, M; Franklin, JM; Hill, EJ; Love, SB; MacGregor, TP; McKenna, WG; Mukherjee, S; Muschel, R; Partridge, M; Quirke, P; Roberts, C; Schnabel, JA; Sharma, RA; Wang, LM; West, N1
Krishnan, S; Meyn, RE; Skinner, HD1

Trials

2 trial(s) available for nelfinavir and Cancer of Rectum

ArticleYear
Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2013, Volume: 107, Issue:2

    Topics: Aged; Chemoradiotherapy; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nelfinavir; Proto-Oncogene Proteins c-akt; Rectal Neoplasms

2013
Clinical Trial of Oral Nelfinavir before and during Radiation Therapy for Advanced Rectal Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Apr-15, Volume: 22, Issue:8

    Topics: Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Combined Modality Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nelfinavir; Neoplasm Metastasis; Neoplasm Staging; Radiation-Sensitizing Agents; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2016

Other Studies

1 other study(ies) available for nelfinavir and Cancer of Rectum

ArticleYear
Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Apr-15, Volume: 22, Issue:8

    Topics: Combined Modality Therapy; Humans; Magnetic Resonance Imaging; Nelfinavir; Radiation Dose Hypofractionation; Radiation-Sensitizing Agents; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome

2016